The critical role of carboxy-terminal amino acids in ligand-dependent and -independent transactivation of the constitutive androstane receptor - PubMed (original) (raw)
The critical role of carboxy-terminal amino acids in ligand-dependent and -independent transactivation of the constitutive androstane receptor
Teemu Andersin et al. Mol Endocrinol. 2003 Feb.
Abstract
The mouse constitutive androstane receptor (CAR) is a unique member of the nuclear receptor superfamily, for which an inverse agonist, the testosterone metabolite 5alpha-androstan-3alpha-ol (androstanol), and an agonist, the xenobiotic 1,4-bis[2-(3, 5-dichloropyridyloxy)] benzene, are known. In this study the role of the transactivation domain 2 (AF-2) of CAR was investigated, which is formed by the seven most carboxy-terminal amino acids of the receptor. The AF-2 domain was shown to be critical for the constitutive activity by mediating a ligand-independent interaction of CAR with coactivator (CoA) proteins. In addition this domain increased and decreased contact with CoAs in the presence of agonist and inverse agonist, respectively. In analogy to classical endocrine nuclear receptors, in CAR the charge clamp between K187 (in helix 3) and E355 (within the AF-2 domain) was expected to be critical for its interaction with CoAs. However, the hydrophobic amino acids L352, L353, and I356 on the surface of the AF-2 domain were found to be more important for this protein-protein interaction. Moreover, these amino acids and C357 were shown to be involved in the response of CAR to androstanol. Interestingly, the cysteine at position 357 appears to block classical endocrine responsiveness of CAR to agonists, since mutagenesis of this amino acid both reduced CoA interaction in the absence of ligand and drastically increased inducibility by 1,4-bis[2-(3, 5-dichloropyridyloxy)] benzene. We showed that this blockade is not due to an intramolecular disulfide bridge, but is probably caused by an interaction between C357 and Y336.
Similar articles
- Antagonist- and inverse agonist-driven interactions of the vitamin D receptor and the constitutive androstane receptor with corepressor protein.
Lempiäinen H, Molnár F, Macias Gonzalez M, Peräkylä M, Carlberg C. Lempiäinen H, et al. Mol Endocrinol. 2005 Sep;19(9):2258-72. doi: 10.1210/me.2004-0534. Epub 2005 May 19. Mol Endocrinol. 2005. PMID: 15905360 - Agonist-dependent and agonist-independent transactivations of the human constitutive androstane receptor are modulated by specific amino acid pairs.
Frank C, Molnár F, Matilainen M, Lempiäinen H, Carlberg C. Frank C, et al. J Biol Chem. 2004 Aug 6;279(32):33558-66. doi: 10.1074/jbc.M403946200. Epub 2004 May 19. J Biol Chem. 2004. PMID: 15151997 - Characterization of activating signal cointegrator-2 as a novel transcriptional coactivator of the xenobiotic nuclear receptor constitutive androstane receptor.
Choi E, Lee S, Yeom SY, Kim GH, Lee JW, Kim SW. Choi E, et al. Mol Endocrinol. 2005 Jul;19(7):1711-9. doi: 10.1210/me.2005-0066. Epub 2005 Mar 10. Mol Endocrinol. 2005. PMID: 15764585 - CAR, the continuously advancing receptor, in drug metabolism and disease.
Qatanani M, Moore DD. Qatanani M, et al. Curr Drug Metab. 2005 Aug;6(4):329-39. doi: 10.2174/1389200054633899. Curr Drug Metab. 2005. PMID: 16101572 Review. - Transactivation functions of the N-terminal domains of nuclear hormone receptors: protein folding and coactivator interactions.
Kumar R, Thompson EB. Kumar R, et al. Mol Endocrinol. 2003 Jan;17(1):1-10. doi: 10.1210/me.2002-0258. Mol Endocrinol. 2003. PMID: 12511601 Review.
Cited by
- Induction of Constitutive Androstane Receptor during the Development of Oxidative Stress.
Shchul'kin AV, Abalenikhina YV, Seidkulieva AA, Ryabkov AN, Yakusheva EN. Shchul'kin AV, et al. Bull Exp Biol Med. 2021 Sep;171(5):615-618. doi: 10.1007/s10517-021-05280-7. Epub 2021 Oct 9. Bull Exp Biol Med. 2021. PMID: 34626280 - High-content analysis of constitutive androstane receptor (CAR) translocation identifies mosapride citrate as a CAR agonist that represses gluconeogenesis.
Mackowiak B, Li L, Lynch C, Ziman A, Heyward S, Xia M, Wang H. Mackowiak B, et al. Biochem Pharmacol. 2019 Oct;168:224-236. doi: 10.1016/j.bcp.2019.07.013. Epub 2019 Jul 12. Biochem Pharmacol. 2019. PMID: 31306645 Free PMC article. - Molecular Basis of Metabolism-Mediated Conversion of PK11195 from an Antagonist to an Agonist of the Constitutive Androstane Receptor.
Mackowiak B, Li L, Welch MA, Li D, Jones JW, Heyward S, Kane MA, Swaan PW, Wang H. Mackowiak B, et al. Mol Pharmacol. 2017 Jul;92(1):75-87. doi: 10.1124/mol.117.108621. Epub 2017 Apr 25. Mol Pharmacol. 2017. PMID: 28442602 Free PMC article. - Mechanisms of xenobiotic receptor activation: Direct vs. indirect.
Mackowiak B, Wang H. Mackowiak B, et al. Biochim Biophys Acta. 2016 Sep;1859(9):1130-1140. doi: 10.1016/j.bbagrm.2016.02.006. Epub 2016 Feb 10. Biochim Biophys Acta. 2016. PMID: 26877237 Free PMC article. Review. - New insights into Vitamin D sterol-VDR proteolysis, allostery, structure-function from the perspective of a conformational ensemble model.
Mizwicki MT, Bula CM, Bishop JE, Norman AW. Mizwicki MT, et al. J Steroid Biochem Mol Biol. 2007 Mar;103(3-5):243-62. doi: 10.1016/j.jsbmb.2006.12.004. J Steroid Biochem Mol Biol. 2007. PMID: 17368177 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Miscellaneous